FDA Releases Draft Guidance on Incorporating Physical-Chemical Identifiers into Drug Products for Anticounterfeiting

Summary

The FDA has announced the availability of a draft guidance document that provides recommendations for pharmaceutical manufacturers on incorporating physical-chemical identifiers into solid oral dosage forms to prevent counterfeiting, and outlines procedures for reporting and requesting approval for postapproval changes.